These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7370771)

  • 1. DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats.
    Jaim-Etcheverry G; Zieher LM
    Brain Res; 1980 Apr; 188(2):513-23. PubMed ID: 7370771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.
    Jonsson G; Hallman H; Ponzio F; Ross S
    Eur J Pharmacol; 1981 Jun; 72(2-3):173-88. PubMed ID: 6265244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel changes in brain flunitrazepam binding and density of noradrenergic innervation.
    Medina JH; Novas ML
    Eur J Pharmacol; 1983 Apr; 88(4):377-82. PubMed ID: 6134628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
    Nowak P
    Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of neonatal vinblastine on peripheral and central noradrenaline neurons.
    Zieher LM; Jaim-Etcheverry G
    Eur J Pharmacol; 1983 Sep; 93(1-2):101-6. PubMed ID: 6628544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
    Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic effects of DSP-4 on the noradrenergic system of the goldfish brain.
    Villani L; Guarnieri T; Facchinetti F; Virgili M; Poli A
    Brain Behav Evol; 1996; 47(5):219-24. PubMed ID: 8724644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
    Archer T; Ogren SO; Johansson G; Ross SB
    Psychopharmacology (Berl); 1982; 76(4):303-9. PubMed ID: 6812102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning.
    Heal DJ; Butler SA; Prow MR; Buckett WR
    Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.
    Introini IB; Baratti CM; Huygens P
    Psychopharmacology (Berl); 1984; 82(1-2):107-12. PubMed ID: 6420819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report.
    Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
    Neurosci Lett; 2010 Sep; 481(2):102-4. PubMed ID: 20599586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Region-specific noradrenaline depletion by neonatal DSP-4: functional consequences and effect on a coexisting neurotransmitter.
    Donnerer J; Amann R; Skofitsch G; Lembeck F
    Eur J Pharmacol; 1990 May; 181(1-2):147-50. PubMed ID: 1974855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart.
    Ross SB
    Br J Pharmacol; 1976 Dec; 58(4):521-7. PubMed ID: 1000130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.